Literature DB >> 25973647

Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification.

Seng Chan You1, Kwang Joon Kim2,3, Seung Up Kim1,4, Beom Kyung Kim1,4, Jun Yong Park1,4, Do Young Kim1,4, Sang Hoon Ahn1,4, Kwang-Hyub Han1,4.   

Abstract

BACKGROUND AND AIM: Non-alcoholic fatty liver disease (NAFLD) has a close relationship with coronary atherosclerosis. We investigated the association between coronary atherosclerosis and liver fibrosis, represented as coronary artery calcification (CAC) score, and live stiffness (LS) value assessed using transient elastography (TE), respectively, in patients with NAFLD.
METHODS: Between January 2013 and March 2014, a total of 285 asymptomatic subjects without chronic liver and ischemic heart diseases who underwent comprehensive medical health check-up were recruited. NAFLD was defined as controlled attenuation parameter (CAP) ≥ 250 dB/m on TE.
RESULTS: The median age of the study population (men 161 and women 124) was 56 (interquartile [IQR], 50-63) years. Of these, 142 (49.8%) subjects had NAFLD. Among subjects with NAFLD, CAC score was independently correlated with the male gender (β = 0.230; P = 0.010), elevated erythrocyte sedimentation rate (β = 0.220; P = 0.019), reduced estimated glomerular filtration rate (β=-0.220; P = 0.004), increased left ventricular mass index (β = 0.226; P = 0.027), and higher LS values (β = 0.274; P < 0.001). In addition, alanine aminotransferase level (β = 0.214, P = 0.012) and CAC score (β = 0.311; P = 0.001) are the only independent factors associated with LS values in subjects with NAFLD.
CONCLUSIONS: Higher CAC score was independently correlated with LS values in subjects with NAFLD. However, it should be further investigated whether TE can be incorporated into a screening tool to identify the high-risk population for coronary artery disease.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  coronary artery calcification; fibroscan; healthy subjects; liver fibrosis; liver stiffness; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; transient elastography

Mesh:

Year:  2015        PMID: 25973647     DOI: 10.1111/jgh.12992

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.

Authors:  Galit Weinstein; Kendra Davis-Plourde; Jayandra J Himali; Shira Zelber-Sagi; Alexa S Beiser; Sudha Seshadri
Journal:  Liver Int       Date:  2019-06-26       Impact factor: 5.828

2.  Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter.

Authors:  Hyo Eun Park; Heesun Lee; Su-Yeon Choi; Min-Sun Kwak; Jong In Yang; Jeong Yoon Yim; Goh Eun Chung
Journal:  J Gastroenterol       Date:  2018-10-04       Impact factor: 7.527

3.  Prevalence and Prognostic Significance of Liver Fibrosis in Patients With Aneurysmal Subarachnoid Hemorrhage.

Authors:  Tiangui Li; Peng Wang; Xiao Gong; Weelic Chong; Yang Hai; Chao You; Juan Kang; Fang Fang; Yu Zhang
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

4.  Higher association of coronary artery calcification with non-alcoholic fatty liver disease than with abdominal obesity in middle-aged Korean men: the Kangbuk Samsung Health Study.

Authors:  Min-Kyung Lee; Hye-Jeong Park; Won Seon Jeon; Se Eun Park; Cheol-Young Park; Won-Young Lee; Ki-Won Oh; Sung-Woo Park; Eun-Jung Rhee
Journal:  Cardiovasc Diabetol       Date:  2015-07-15       Impact factor: 9.951

Review 5.  The ABCC6 Transporter: A New Player in Biomineralization.

Authors:  Guillaume Favre; Audrey Laurain; Tamas Aranyi; Flora Szeri; Krisztina Fulop; Olivier Le Saux; Christophe Duranton; Gilles Kauffenstein; Ludovic Martin; Georges Lefthériotis
Journal:  Int J Mol Sci       Date:  2017-09-11       Impact factor: 5.923

6.  Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.

Authors:  Gyuri Kim; Kwang Joon Kim; Yumie Rhee; Sung-Kil Lim
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

Review 7.  Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.

Authors:  Abdulrahman Ismaiel; Dan L Dumitraşcu
Journal:  Front Med (Lausanne)       Date:  2019-09-13

8.  Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Do Seon Song; U Im Chang; Sung-Goo Kang; Sang-Wook Song; Jin Mo Yang
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

9.  Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver Transplantation.

Authors:  Audrey Laurain; Isabelle Rubera; Micheline Razzouk-Cadet; Stéphanie Bonnafous; Miguel Albuquerque; Valérie Paradis; Stéphanie Patouraux; Christophe Duranton; Olivier Lesaux; Georges Lefthériotis; Albert Tran; Rodolphe Anty; Philippe Gual; Antonio Iannelli; Guillaume Favre
Journal:  Biomedicines       Date:  2022-06-24

10.  Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease.

Authors:  Eugene Han; Yong-Ho Lee; Jae Seung Lee; Hye Won Lee; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Byung-Wan Lee; Eun Seok Kang; Bong-Soo Cha; Seung Up Kim
Journal:  Gut Liver       Date:  2022-03-24       Impact factor: 4.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.